Status:
COMPLETED
Evaluation of the H-coil Transcranial Magnetic Stimulation TMS Device - Safety and Feasibility Study for Acute and Maintenance Treatment in Major Depressive Episode
Lead Sponsor:
Shalvata Mental Health Center
Collaborating Sponsors:
Brainsway
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This is a prospective open label study of acute and maintenance treatment of MDD. The acute phase consists of daily treatments for 4 weeks. maintenance will be twice a week for eight weeks followed by...
Eligibility Criteria
Inclusion
- MDD patients
Exclusion
- risk factors for convulsions
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT00807105
Start Date
June 1 2008
End Date
May 1 2010
Last Update
January 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ShalvataMHC
Hod HaSharon, Israel, Israel